ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
15
views
0
references
Top references
cited by
47
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,949
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Current approaches and future directions in the treatment of HER2-positive breast cancer
Author(s):
Sara A Hurvitz
,
Yufang Hu
,
Neil S. O’Brien
,
Richard Finn
Publication date:
2013-05-01
Journal:
Cancer treatment reviews
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PMC
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Alternative approaches to Alzheimer's Disease
Author and article information
Journal
DOI::
10.1016/j.ctrv.2012.04.008
PMC ID::
3835685
PubMed ID::
22658319
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,949
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
Authors:
George Fountzilas
,
Urania Dafni
,
Mattheos Bobos
…
Therapeutic implication of HER2 in advanced biliary tract cancer
Authors:
Ah-Rong Nam
,
Ji Kim
,
Yongjun Cha
…
Downregulation of HER3 by a novel antisense oligonucleotide, EZN-3920, improves the antitumor activity of EGFR and HER2 tyrosine kinase inhibitors in animal models.
Authors:
D Horak
,
Z. Qu
,
Ying-Lian Gao
…
See all similar
Cited by
44
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
Authors:
Pei Ong
,
Louis Wang
,
Xiaoyun Dai
…
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.
Authors:
A. Labrijn
,
J. Meesters
,
B. E. C. G. de Goeij
…
SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer
Authors:
Jisheng Bao
,
Liping Zhu
,
Meng-Qi Zhu
…
See all cited by
Version 1
- Current
Version 1